328 related articles for article (PubMed ID: 27046338)
1. Activation of Peroxisome Proliferator-activated Receptor γ Prevents Development of Heart Failure With Preserved Ejection Fraction; Inhibition of Wnt-β-catenin Signaling as a Possible Mechanism.
Kamimura D; Uchino K; Ishigami T; Hall ME; Umemura S
J Cardiovasc Pharmacol; 2016 Aug; 68(2):155-61. PubMed ID: 27046338
[TBL] [Abstract][Full Text] [Related]
2. Delayed Repolarization Underlies Ventricular Arrhythmias in Rats With Heart Failure and Preserved Ejection Fraction.
Cho JH; Zhang R; Kilfoil PJ; Gallet R; de Couto G; Bresee C; Goldhaber JI; Marbán E; Cingolani E
Circulation; 2017 Nov; 136(21):2037-2050. PubMed ID: 28974519
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates left ventricular remodeling and failure after experimental myocardial infarction.
Shiomi T; Tsutsui H; Hayashidani S; Suematsu N; Ikeuchi M; Wen J; Ishibashi M; Kubota T; Egashira K; Takeshita A
Circulation; 2002 Dec; 106(24):3126-32. PubMed ID: 12473562
[TBL] [Abstract][Full Text] [Related]
4. Low-level transcutaneous vagus nerve stimulation attenuates cardiac remodelling in a rat model of heart failure with preserved ejection fraction.
Zhou L; Filiberti A; Humphrey MB; Fleming CD; Scherlag BJ; Po SS; Stavrakis S
Exp Physiol; 2019 Jan; 104(1):28-38. PubMed ID: 30398289
[TBL] [Abstract][Full Text] [Related]
5. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
Kobayashi M; Machida N; Mitsuishi M; Yamane Y
Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
[TBL] [Abstract][Full Text] [Related]
6. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
Nakajima Y; Ito S; Asakura M; Min KD; Fu HY; Imazu M; Hitsumoto T; Takahama H; Shindo K; Fukuda H; Yamazaki S; Asanuma H; Kitakaze M
J Mol Cell Cardiol; 2019 Apr; 129():257-265. PubMed ID: 30880253
[TBL] [Abstract][Full Text] [Related]
7. Limited Impact of β-Adrenergic Receptor Activation on Left Ventricular Diastolic Function in Rat Models of Hypertensive Heart Disease.
Bamaiyi AJ; Norton GR; Peterson V; Norman G; Mojiminiyi FB; Woodiwiss AJ
J Cardiovasc Pharmacol; 2018 Nov; 72(5):242-251. PubMed ID: 30403389
[TBL] [Abstract][Full Text] [Related]
8. Diosmin attenuates radiation-induced hepatic fibrosis by boosting PPAR-γ expression and hampering miR-17-5p-activated canonical Wnt-β-catenin signaling.
Hasan HF; Abdel-Rafei MK; Galal SM
Biochem Cell Biol; 2017 Jun; 95(3):400-414. PubMed ID: 28177765
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective mechanism of telmisartan via PPAR-gamma-eNOS pathway in dahl salt-sensitive hypertensive rats.
Kobayashi N; Ohno T; Yoshida K; Fukushima H; Mamada Y; Nomura M; Hirata H; Machida Y; Shinoda M; Suzuki N; Matsuoka H
Am J Hypertens; 2008 May; 21(5):576-81. PubMed ID: 18437150
[TBL] [Abstract][Full Text] [Related]
10. Ca2+ entry mode of Na+/Ca2+ exchanger as a new therapeutic target for heart failure with preserved ejection fraction.
Kamimura D; Ohtani T; Sakata Y; Mano T; Takeda Y; Tamaki S; Omori Y; Tsukamoto Y; Furutani K; Komiyama Y; Yoshika M; Takahashi H; Matsuda T; Baba A; Umemura S; Miwa T; Komuro I; Yamamoto K
Eur Heart J; 2012 Jun; 33(11):1408-16. PubMed ID: 21490055
[TBL] [Abstract][Full Text] [Related]
11. Glucocorticoids activate cardiac mineralocorticoid receptors in adrenalectomized Dahl salt-sensitive rats.
Ohtake M; Hattori T; Murase T; Takahashi K; Takatsu M; Ohtake M; Miyachi M; Watanabe S; Cheng XW; Murohara T; Nagata K
Nagoya J Med Sci; 2014 Feb; 76(1-2):59-72. PubMed ID: 25129992
[TBL] [Abstract][Full Text] [Related]
12. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
[TBL] [Abstract][Full Text] [Related]
13. Dual Endothelin-A/Endothelin-B Receptor Blockade and Cardiac Remodeling in Heart Failure With Preserved Ejection Fraction.
Valero-Munoz M; Li S; Wilson RM; Boldbaatar B; Iglarz M; Sam F
Circ Heart Fail; 2016 Nov; 9(11):. PubMed ID: 27810862
[TBL] [Abstract][Full Text] [Related]
14. Prevention of heart failure with preserved ejection fraction (HFpEF): reexamining microRNA-21 inhibition in the era of oligonucleotide-based therapeutics.
Ben-Nun D; Buja LM; Fuentes F
Cardiovasc Pathol; 2020; 49():107243. PubMed ID: 32629211
[TBL] [Abstract][Full Text] [Related]
15. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
16. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction.
Alex L; Russo I; Holoborodko V; Frangogiannis NG
Am J Physiol Heart Circ Physiol; 2018 Oct; 315(4):H934-H949. PubMed ID: 30004258
[TBL] [Abstract][Full Text] [Related]
18. Long-term pharmacological activation of PPARgamma does not prevent left ventricular remodeling in dogs with advanced heart failure.
Suzuki G; Khanal S; Rastogi S; Morita H; Mishima T; Anagnostopoulos PV; Nass O; Sharov VG; Tanhehco EJ; Goldstein S; Sabbah HN
Cardiovasc Drugs Ther; 2007 Feb; 21(1):29-36. PubMed ID: 17294127
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone attenuates cardiac hypertrophy in rats with salt-sensitive hypertension: role of activation of AMP-activated protein kinase and inhibition of Akt.
Kato MF; Shibata R; Obata K; Miyachi M; Yazawa H; Tsuboi K; Yamada T; Nishizawa T; Noda A; Cheng XW; Murate T; Koike Y; Murohara T; Yokota M; Nagata K
J Hypertens; 2008 Aug; 26(8):1669-76. PubMed ID: 18622247
[TBL] [Abstract][Full Text] [Related]
20. Chronic administration of oral vasopressin type 2 receptor antagonist tolvaptan exerts both myocardial and renal protective effects in rats with hypertensive heart failure.
Morooka H; Iwanaga Y; Tamaki Y; Takase T; Akahoshi Y; Nakano Y; Fujiki H; Miyazaki S
Circ Heart Fail; 2012 Jul; 5(4):484-92. PubMed ID: 22628529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
